IRLAB: Final patient enrolled in Pirepemat study
Research Note
2024-09-30
15:04
Redeye gives a short comment on today’s news that IRLAB has enrolledthe last patient in the ongoing phase IIb Pirepemat, in line with expectations
Fredrik Thor
Disclosures and disclaimers